chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient's most severe symptoms include severe migraine x 36hr and orthostasis x 2 days. Also reports vomiting x 1day, fever, chills, weakness, losing control of bowel movements, and loss of appetite, eye pain (associates with migraines). Continues to feel weak/tired and have queasy stomach.
No Adverse Effect noted, Resident administered expired Booster  Moderna vaccine, expired on 10/13/2021.
This spontaneous report was received from a Journalist refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with GARDASIL for (dose, route and lot # were not reported). On an unknown date, the patient experienced unspecified adverse effects that has left her wheelchair bound, after receiving GARDASIL. The outcome of unspecified adverse effects that has left her wheelchair bound was unknown. This is one report of several reports from the same source (MARRS # 1408USA001101). This case was considered medically significant due to patient disabling. Additional information has been requested.
9/26 = Left eye became sore to touch; 9/28 = Left eye vision loss; 9/29 = Primary eye MD referred her to ophthalmologist; 9/30 = ophthalmologist ordered MRI due to optic neuritis; 9/31 = MRI completed; 10/2 = Ophthalmologist ordered her to be admitted to hospital for further work-up. She received high doses of steroids and was admitted for 3 days; 11/4 = followed-up with neurologist. Outcome = optic neuritis has improved and she has regained most of her vision in the left eye.
Fatigue/Tired, muscle pain in legs and torso, headache & nausea
Patient received a Tdap, then went for lab work. Patient had been fasting for blood tests, doesn't like needles and fainted when waiting for blood work to be done. Vitals stable, patient was moved to lying position and assessed by provider. No treatment necessary.
Initial and follow-up information has been received from an official concerning a female who was vaccinated with GARDASIL vaccine (yeast) at the gluteal region. It was stated that the girl was vaccinated this way because there was not enough muscle mass to vaccinate the intended way. No symptoms were noted. It was not specified if the patient sought medical attention or not. This is one of several reports received from the same source. Additional information has been requested.
Tingling in hands and now feet; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Ew0179), via an unspecified route in the left arm on 06May2021 at 09:00 (at the age of 65 years) as 2nd dose, single for COVID-19 immunisation. The patient medical history included high cholesterol, acid reflux, familial tremors, weak bladder. The patient's had unspecified concomitant medications within 2 weeks of vaccination. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Ew0169) via an unspecified route in the arm left on 15Apr2021 at 09:15 as 1st dose, single for COVID-19 immunisation. On 15May2021 at 09:00, the patient experienced tingling in hands and now feet. Started about 9 days after 2nd dose in hands and now was affecting feet. Patient received no treatment for the events. Since vaccination patient was not tested for COVID 19. The outcome of event was not recovered.  No follow up attempts are possible. No further information is expected.
Pt noticed swelling & itching in Lt arm around site of injection 1 day after receiving vaccine.  The swelling & redness have enlarged to include entire upper left arm at 3 days post vaccination.  Pt was referred to MD.
4th dose in series injected left IM deltoid around 10am. Patient later reported back at 1:45pm same day, experiencing soreness at the injection site, along with tingling and numbness that radiated from the injection site down to the hand. Patient was concerned whether that this was a normal side effect. I informed patient that these side effects have been reported in the past and referred patient to advice nurse to see if further evaluation same day is needed. Patient called advice nurse and informed me that this is a rare side effect, and that the nurse instructed patient to continue self-monitoring and to report back if side effects worsen. Unclear if patient has recovered from side effects and the time of this report.
Red, warm, lesion antimedial aspect left thigh. No temp 1.5cm x 2cm firm, red, non tender lesion
Patient was waiting out her 15 mins in the waiting room after receiving the first dose of her Moderna COVID19 vaccine when she began to fill like her tongue was a little swollen. Brought patient into an exam room and took her vitals at 1028 which were BP 135/83, HR 82, O2 96%, and RR 15. Also looked at patients throat to assess signs of angioedema or restricted airway. Patients tongue did appear swollen and was unable to clearly see the back of her throat. 1020 IM Benadryl 50mg was given per standing order and retook vitals at 1032 vitals remained stable at BP 131/52, HR 79, and O2 96%. Patient was moved to a more private room and laid down on a yoga matt for 15-20 min. She began to feel better and continued to be able to swallow and maintain airway. Tongue swelling does appear to have decreased. Could not see uvula but patient states she is not sure if you ever can she may have different anatomy. Vital taken for final time around 1100 and were BP 125/76 O2 96% and HR 74 which she says is normal for her. Made patient aware that after her husband drives her home that she should monitor symptoms and if they become worse she needs to call 911. Scheduled second dose of vaccine but told her to anticipate getting vaccine in Urgent care if okay with Director.
Muscle twitching; tremors; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 31Mar2021 at 09:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown duration and COVID-19 prior to vaccination. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) taken for an unknown indication and received within two weeks of vaccination. The patient did not had allergy to any medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 10:00, the patient experienced muscle twitching and tremors. Right arm twitch started right after the vaccination and later when the patient went to bed both arms started having uncontrollable twitches and tremors including legs too. It keeps happening but it was lessening. The patient did not receive any treatment for the event. The clinical outcome of the events muscle twitching and tremors were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Anxiety attack lasting 2 hours,. Took some benadryl and wellbutrin. Within 40 minutes calmed down enough, until the next day started feeling shaky and anxious again..called Dr. at home. She says to take my wellbutrin in the morning as well as my evening dose and benedryl every 4 hours. Has been good since then.
Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 93 year old female patient. No information was provided regarding medical history, concurrent conditions, concomitant medications, drug reactions or allergies. On or about 17-APR-2008, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, lot #, expiration date, route of administration and anatomical location were not provided)) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced Shingles. She was treated by a physician for the event. The outcome of the event of shingles was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  Additional information has been requested.
Immediate burning at injection site & from elbow to wrist. Persistant pain in area around injection site (about hand-sized area) and occasional burning sensation at injection site.
Information has been received from a registered nurse concerning an outbreak of chicken in a child, between the ages of kindergarten to 4th grade, who had been vaccinated subcutaneously with a first dose of 0.5 mL of varicella virus vaccine live (Oka/Merck). Subsequently, the child developed chickenpox. The child may have 50 lesions or more. Additional information is not expected. This is one of several reports from the same source.
GBS & short term memory loss are reported in pt who recvd flu vax; 1DEC93 pt exp onset of weakness & tingling of the extremities; pt currently noticed short term memory loss;could no long stand; hospitalized for 6 to 7 days
Redness spanning 2.5? diameter, raised site of injection of the same size, extreme tenderness of the raised area only- monitored redness by circling with marker, noted at 6 am morning after injection, minor decrease in diameter to 2? at 9 pm (15 hrs later)
Patient began shaking, had shortness of Breath, Increased heart rate 148, low o2 sat 90 increased temp 99.5 respirations were 38 B/P 144/70 blood sugar 198
had frequent bowel movements; This spontaneous case was reported by a patient and describes the occurrence of FREQUENT BOWEL MOVEMENTS (had frequent bowel movements) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 14-Jan-2021, the patient experienced FREQUENT BOWEL MOVEMENTS (had frequent bowel movements). At the time of the report, FREQUENT BOWEL MOVEMENTS (had frequent bowel movements) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient drank the poly glyco prep on 14-Jan-2021 as treatment. Patient did  colonoscopy prep for his procedure 15-Jan-2021.
Patient presented to ER with generalized myalgias/arthralgias, headache, nausea, cramping. Initial symptoms began about 12 hours post Twinrix and Td immunization. Symptomatic improvement after Ketorolac IM.
Redness and swelling at the injection site beginning 12 hours after injection - lasted about 72 hours. Fever for 48 hours. Gave BENADRYL/ZANTAC/ice packs/ibuprofen.
This spontaneous report was received from a pharmacist referring to a 55 year old patient of unknown gender, who on 20-AUG-2013, was vaccinated with a dose of ZOSTAVAX, 0.65 ml, subcutaneous (lot # J003796, expiration date 28-JUN-2014). The pharmacist reported that the patient who received ZOSTAVAX, on 20-AUG-2013, presented to the pharmacy the following day with a raised, warm hive- or wheal-like area approximately 3 inches by one inch. She stated that the area was definitely not a rash; it looked more like an allergic reaction to the ZOSTAVAX. The pharmacist did not specify if this patient notified her physician, or if the affected area has resolved. She did state that she did not have a lot of the patient's medical history on hand. The pharmacist was requesting a lot check for ZOSTAVAX (lot # J003796, expiration 28-JUN-2014), since two other patients have also reported adverse effects since receiving ZOSTAVAX of this lot. This is one of several reports from the same reporter source. Additional information has been requested.
FYI- when I had COVID-19 in November 2020 I lost my taste and smell and had sinus-infection symptoms.   Within 18 hours of the first vaccine shot I had an overwhelming fatigue and low-grade fever of about 100 degrees and needed to rest the remainder of the day and into the next.  I may have noticed some slight changes in tastes prior to February 25th, but I don't think so.  On this particular night I had a Sprite- it tasted very bad- like cleanser and horseradish and floral.  I started to have other things taste like this including my toothpaste, A1 steak sauce.  My family tasted these items too and said they were fine.  At one meal my family said the mushrooms didn't taste fresh and that they might be expired, but I couldn't taste the difference. I messaged my doctor who said it was okay to get the second shot.  My taste-senses were still out of whack when I received the second dose on Mar 14. Within about 18 hours of the second vaccine shot I had a bad headache and a low-grade fever of about 101 degrees.  I was in bed all day.  I didn't feel great the next day but went to work and noticed that my yogurt drink had an odd flavor- strawberry banana had the flavor of sage/horseradish.   There have been a number of more items that do not taste good anymore.
Sore right eye prior to vaccination and stuffy nose prior to vaccination.  Headache (6 out of 10) and runny nose started after receiving vaccine.  BP 145/89  HR \=76  O2=96% and Temp=98.6F at 1:55pm.  BP 142/89  HR=67  Temp=98.6F,  O2=96% at 2:05pm.  Patient reports having allergies prior to receiving vaccine, but nose started running excessively after receiving the vaccine.  Vision started to blur in right eye.  Offered patient to go to ED, but he didn't feel the need to.  He will contact his physician, if necessary.  Patient clinically stable.  Patient released from clinic at 2:18pm.
Post first vaccine, patient experienced hair loss (#2 patches of hair missing), headaches, joint pain between days 1-4 and lasted over 7 days. Post the second vaccine, patient experienced hair loss (#15 patches of hair missing),  headaches and worse joint pain between days 1+ and still experiencing during submission of this report.   Patient has had lab work completed and TSH was elevated and created a cascading event of immune response.
Two days after receiving the first shot I have lost my sense of taste. The smell comes and goes. I also completed the second dose at the same location. Pfizer EW0153
Patient complained of dull frontal headache after vaccination, drank water, observed for 30 minutes at which point headache resolved.
Within two minutes of receiving the vaccination, she developed lightheadedness, sweating, and nausea. She was taken to a private section of the arena and monitored. Vitals were within normal limits. Her symptoms resolved after 10 minutes of monitoring.
pt recvd 1st dose of Hep B vax on 31JAN92 & the next day devel rt upper quad pain which lasted approx 2 days; No further details were provided;
On 07/25/2000, the patient developed a maculopapular rash that included greater than 30 lesions on his arms, legs, abdomen, and back. Some of the lesions were reported crusted and scabbed over. The patient also developed a fever and lethargy. After being seen by a physician it was felt that the patient's symptoms were not chickenpox, "but were more consistent with duck itch, which is a term used to describe mite bites that children get when swimming in water inhabited by ducks." Four additional patients had similar experiences following exposure to varicella virus vaccine live. Follow up information indicated that a specimen was sent for PCR analysis, however, the specimen was inadequate to process. Additional information has been requested.
Therapy non-responder  This case was reported by a nurse and described a subject (age and gender unknown) who did not respond to immunization to hepatitis B vaccine recombinant (Engerix-B).  On unspecified dates, the subject received Engerix-B. On an unspecified date before 12 May 2006, a hepatitis B surface antibody titer was negative.  It was reported that the titers were taken from one to five months after the third dose of Engerix-B was received. No adverse events were reported.
rash at injection site.  about 3 inches in diameter.  it itched the first day, but after applying benadryl cream, the itch went away.  i applied benadryl every 6 hours and it seems to be helping.  it is 36 hours later after initial symptoms, and it seems like it is mostly taken care of.
I received the vaccine and the sat to wait the 15 minutes of observation. Within 5 minutes of receiving the vaccine I started to feel flushed and felt my heart rate increasing . They took my vitals and my heart rate increased to 175. I was taken to the Emergency room. Given IV fluids, IV benadryl, and  monitored. My heart rate came down but continues to stat at 90-100s at rest.  Almost 24 hours in now and I am very weak with no energy.  I still get dizzy intermittently and my heart rate increases easily.
Noticed feeling extremely lethargic, heart rate increased, had grand mal seizure. Spouse said that the event was not as long or aggressive as typical grand mal episodes. Previously seizure-free for over a year and a half. Last blood lamotrigine levels tested 3/02/2021 and was out of standard range on the low end. Dosage of lamotrigine increased to compensate (225 mg AM/200 mg/PM) after obtaining results.  Dosage increased again (225 mg 2x/day) after seizure episode. Pending blood level retest in May. Event is likely due to low medicinal levels aggravated by immune response.   First pregnancy, event occurred at 30 weeks gestation. Estimated delivery 6/17/2021. Seizure occurred in bed and no physical external damage happened to the abdomen. Fetal movement is typical and predictable.
the patient received an improperly stored dose of Rotateq; This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, concomitant medications and previous drug reactions or allergies was reported.  On 17-AUG-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot number 1660981 was verified to be valid, expiration date reported and validated as 13-APR-2021 (dose, route of administration and anatomical location were not provided) for prophylaxis.  The administered dose of vaccine experienced a temperature excursion of 9.1 Celsius degrees for 37 minutes. There was no previous temperature excursion. Digital Data Logger was involved
Patient called the pharmacy and reported having pain 8/10, difficulty breathing deeply, and shoulder pain radiating to her back with some numbness in the arm that was vaccinated.  I told her to immediately seek medical attention (told her to go to the ED) due to the difficulty breathing.
guillain barre syndrome; Coma; This case was reported by a pharmacist via call center representative and described the occurrence of guillain barre syndrome in a adult male patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced guillain barre syndrome (serious criteria hospitalization and GSK medically significant) and coma (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome and coma were unknown.   The reporter considered the guillain barre syndrome and coma to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received flu shot several years ago and experienced Guillain-barre syndrome, which led to hospitalization and coma. The reporter was uncertain of which vaccine the patient received and stated that, it may be quadrivalent or trivalent. The reporter consented to follow up.
This spontaneous report was received on 27-APR-2018 from a consumer concerning his 11 year old daughter. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On an unspecified date in April 2018 (also reported as last week), the patient was vaccinated with GARDASIL 9, (lot number, dosage, and route of administration not provided). The reporter stated that "one day later, the patient started acting differently, had problems breathing and wet the bed" (no further information was provided). The outcome of acting differently, problems breathing and wet the bed was reported as not recovered. Additional information has been requested.
sore muscle w/in 24 hrs itching, burning about 2 finger lenghts above inject site; red area the size of a dime; itching, scaling-soreness form elbow to arm pit;
Both my hands numb; both my feet numb; lightheaded; shortness of breath; feel like i was going to faint; heart was beating fast; injection site swollen; A report was received from a physician concerning a female patient who was participating in the mRNA-1273 Emergency Use Program and experienced the events both my hands numb, both my feet numb, lightheaded, shortness of breath, feel like I was going to faint, heart was beating fast and injection site swollen.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 27 Dec 2020, around 11:15 or 11:30 am, approximately 0 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 27 Dec 2020, the patient reported experiencing numbness in both hands and feet, lightheadedness, shortness of breath, feeling like she was going to faint, and increased heart rate following vaccine administration. She was given oral Benadryl for her symptoms. Around 7:00 pm that night, the patient experienced a reoccurrence of numbness and took Benadryl again before going to sleep.   On 29 Dec 2020, the patient reported feeling better but was still experiencing injection site swelling. She plans to do a skin allergy test and inquired about the vaccine ingredients.   Treatment for the event included oral Benadryl.   Action taken with mRNA-1273 in response to the events was not reported.  The events, both my hands numb, both my feet numb, lightheaded, shortness of breath, feel like I was going to faint, heart was beating fast, were considered resolved on 29 Dec 2020. The outcome of the event, injection site swollen, was unknown.  The reporter did not provide an assessment for the events, both my hands numb, both my feet numb, lightheaded, shortness of breath, feel like I was going to faint, heart was beating fast and injection site swollen.; Reporter's Comments: This case concerns a female patient of unknown age. The patient's medical history was not provided. The patient experienced NS, unexpected events of Dizziness, increased heart rate, dyspnea, Pre syncope, hypoaesthesia of hands and feet and expected event of injection site swelling. The events of  Dizziness, increased heart rate, dyspnea, Pre syncope, hypoaesthesia of hands and feet occurred in 15 minutes after the first dose of mRNA-1273 was administered and injection site swelling occurred on an unknown date. Treatment for the event included oral Benadryl. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
2 reactions to diff vax. Day of vax, fever, red circle, swollen area on R thigh where Hep B injection given. 2 days post vax, swollen area on L thigh increased to 3", hot to touch. No fever at this pt. Keflex given.
Loss of nearly all smell (95% loss) about a month after receiving the J&J COVID vaccine.  Smell has not returned.